Investors
Novartis Venture Fund
A corporate venture capital firm in Switzerland that focuses on companies that develop novel therapeutics and platforms
Recent Investments
- CatalYmSeries D(
56 ) - EpsilogenSeries B( 52 )
- EpsilogenSeries B( 52 )
- DeciphexSeries B( 31 )
- AstronauTxSeries A( 48 )
- CatalYmUnknown( 56 )
- EpsilogenUnknown( 52 )
- EpsilogenUnknown( 52 )
- DopavisionSeries A( 37 )
- AnaveonUnknown( 48 )
- Splice BioSeries A( 26 )
- Rappta TherapeuticsSeries A( 37 )
- CatalYmSeries B( 56 )
- AnaveonSeries A( 48 )
- Enterprise TherapeuticsSeries B( 52 )